{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:23:40Z","timestamp":1790105020538,"version":"4.0.1"},"reference-count":74,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2020,9,21]]},"abstract":"<jats:p>\n                    Antibiotic resistance is a threat to public health, and uncomplicated urinary tract infections (uUTIs) are an example of this concern. This systematic review (International Prospective Register of Systematic Reviews [PROSPERO] ID: CRD42020156674) is the first to determine the prevalence of\n                    <jats:named-content content-type=\"genus-species\">Escherichia coli<\/jats:named-content>\n                    resistance to fluoroquinolones in women with community-acquired uUTI. PubMed and Embase searches were conducted; 38 studies fulfilled eligibility criteria and were included in the systematic review.\n                  <\/jats:p>","DOI":"10.1128\/aac.00862-20","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T09:07:05Z","timestamp":1596445625000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":82,"title":["Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review"],"prefix":"10.1128","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0130-8659","authenticated-orcid":false,"given":"Ann E.","family":"Stapleton","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2909-0797","authenticated-orcid":false,"given":"Florian M. E.","family":"Wagenlehner","sequence":"additional","affiliation":[{"name":"Department of Urology, Pediatric Urology and Andrology, Justus Liebig University, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruni","family":"Mulgirigama","sequence":"additional","affiliation":[{"name":"GSK Global Specialty and Primary Care, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Twynholm","sequence":"additional","affiliation":[{"name":"GSK Medicines Research Centre, Stevenage, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(03)00005-9"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/547848"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-010-0178-x"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq286"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2019.02.021"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-010-9777-9"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp17X693641"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq257"},{"key":"e_1_3_4_10_2","volume-title":"EAU guidelines on urological infections","author":"Bonkat G","year":"2019","unstructured":"Bonkat G, Pickard R, Bartoletti R, Cai T, Bruy\u00e8re F, Geerlings SE, K\u00f6ves B, Wagenlehner F. 2019. EAU guidelines on urological infections. European Association of Urology, Arnhem, The Netherlands. https:\/\/uroweb.org\/guideline\/urological-infections\/."},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.02.002"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2018.50.1.67"},{"key":"e_1_3_4_13_2","volume-title":"FDA drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects","author":"US Food and Drug Administration","year":"2016","unstructured":"US Food and Drug Administration. 2016. FDA drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. US Food and Drug Administration, Harrisburg, PA. https:\/\/www.fda.gov\/media\/99425\/download."},{"key":"e_1_3_4_14_2","volume-title":"FDA updated warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions","author":"US Food and Drug Administration","year":"2018","unstructured":"US Food and Drug Administration. 2018. FDA updated warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions. US Food and Drug Administration, Harrisburg, PA. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-updates-warnings-fluoroquinolone-antibiotics-risks-mental-health-and-low-blood-sugar-adverse."},{"key":"e_1_3_4_15_2","volume-title":"Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone of fluoroquinolone antibiotics","author":"European Medicines Association","year":"2019","unstructured":"European Medicines Association. 2019. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone of fluoroquinolone antibiotics. European Medicines Association, Amsterdam, The Netherlands. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/quinolone-fluoroquinolone-article-31-referral-disabling-potentially-permanent-side-effects-lead_en.pdf."},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy198"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw159"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku005"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00120-018-0848-3"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx465"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw399"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3804-y"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1282-4"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2015.0241"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2010.02.013"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw302"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2009.04.012"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.09.013"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-015-0095-5"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-12-33"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2789-7"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03655-3"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3785-x"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-016-2673-1"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-016-2776-8"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2017.12.006"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.2310\/8000.2012.120666"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0000000000000721"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01188-08"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2010.10.032"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-011-0241-2"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.07.011"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2010.25.8.1205"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177266"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2009.03.027"},{"key":"e_1_3_4_46_2","first-page":"824","article-title":"E. coli resistance to ciprofloxacin and common associated factors","volume":"25","author":"Jadoon RJ","year":"2015","unstructured":"Jadoon RJ, Jalal-Ud-Din M, Khan SA. 2015. E. coli resistance to ciprofloxacin and common associated factors. J Coll Physicians Surg Pak 25:824\u2013827.","journal-title":"J Coll Physicians Surg Pak"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-8-27"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02941.x"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-019-1612-6"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01315-13"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4192908"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-012-0419-2"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16183376"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013719"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209580"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-6804-3"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-04981-0"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2015.04.067"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00337-18"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6783"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamainternmed.305"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.07.001"},{"key":"e_1_3_4_63_2","volume-title":"Assessing non-prescription and inappropriate use of antibiotics","author":"World Health Organization Regional Office for Europe","year":"2019","unstructured":"World Health Organization Regional Office for Europe. 2019. Assessing non-prescription and inappropriate use of antibiotics. Report on survey. World Health Organization, Geneva, Switzerland. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/312306\/9789289054089-eng.pdf."},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00370"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00528-16"},{"key":"e_1_3_4_66_2","volume-title":"Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline (2019)","author":"Anger J","year":"2019","unstructured":"Anger J, Lee U, Ackerman AL. 2019. Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline (2019). American Urological Association, Linthicum Heights, MD. https:\/\/www.auanet.org\/guidelines\/recurrent-uti."},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-1-200107030-00004"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2785-y"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011458"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-137"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2009.08.018"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-228"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-019-01361-y"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2015.02.022"}],"updated-by":[{"DOI":"10.1128\/aac.02209-21","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000}}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00862-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00862-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:36:32Z","timestamp":1645468592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00862-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,9,21]]}},"alternative-id":["10.1128\/AAC.00862-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.00862-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"2020-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00862-20"}}